Capacities of blood serum lipoarabinomannan in the diagnosis of tuberculosis at a late stage of HIV infection

A. Dudchenko (Moscow, Russian Federation), M. Averbakh (Moscow, Russian Federation), N. Karpina (Moscow, Russian Federation), A. Ergeshov (Moscow, Russian Federation)

Source: International Congress 2018 – The immune response to tuberculosis: development of biomarkers and diagnostic tools
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Dudchenko (Moscow, Russian Federation), M. Averbakh (Moscow, Russian Federation), N. Karpina (Moscow, Russian Federation), A. Ergeshov (Moscow, Russian Federation). Capacities of blood serum lipoarabinomannan in the diagnosis of tuberculosis at a late stage of HIV infection. 4738

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Evaluation of IP-10 in blood serum for TB diagnosis in patients with late-stage HIV infection
Source: International Congress 2019 – Tuberculosis: diagnosis and scores
Year: 2019

The significance of IP-10 level in blood serum for TB diagnosis in patients with late-stage HIV infection
Source: International Congress 2019 – Tuberculosis: diagnosis
Year: 2019

Role of detection of lipoarabinomannan (LAM) in urine for diagnosis of tuberculosis in HIV patients; Egyptian experience
Source: International Congress 2017 – Human susceptibility to tuberculosis
Year: 2017

Performance of blood tests for the diagnosis of latent tuberculosis infection in children
Source: Annual Congress 2008 - New methods to diagnose tuberculosis infection and disease
Year: 2008

The use of interferon-γ-based blood tests for the detection of latent tuberculosis infection
Source: Eur Respir J 2006; 28: 1-3
Year: 2006


Relationship of immunodiagnostic assays for tuberculosis and numbers of circulating CD4+ T-cells in HIV infection
Source: Eur Respir J 2010; 35: 619-626
Year: 2010



Contribution of a whole blood IFN-gamma release assay for diagnosis of M. tuberculosis infection in BCG-vaccinated children
Source: Annual Congress 2008 - New tests and methods to diagnose tuberculosis infection and disease and to monitor treatment
Year: 2008


Utility of MPT64 antigen detection test for diagnosis of HIV coinfected extrapulmonary tuberculosis in Tanzania
Source: International Congress 2019 – Tuberculosis: diagnosis and scores
Year: 2019


Multiple cytokine response to mycobacterium tuberculosis with a whole blood assay is useful to distinguish active from latent tuberculosis infection in a highly tuberculosis endemic country
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2
Year: 2014


Evaluation of D-dimer levels in patients with active pulmonary tuberculosis and latent tuberculosis infection
Source: Eur Respir J 2006; 28: Suppl. 50, 164s
Year: 2006

Response to Rv2628 latency antigen associates with cured tuberculosis and remote infection
Source: Eur Respir J 2010; 36: 135-142
Year: 2010



Disseminated nontuberculous pulmonary mycobacteriosis in patients at late stages of HIV infection
Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II
Year: 2019

The specificity of interferon-γ-based blood tests in the identification of latent tuberculosis infection
Source: Eur Respir J 2006; 28: 1283
Year: 2006


Usefulness of serum anti-glycopeptidolipid core IgA antibody assay for the diagnosis of pulmonary infection of mycobacterium avium complex
Source: International Congress 2014 – Tuberculosis: diagnosis
Year: 2014


Characterization of the HBHA response in TB patients with or without HIV infection.
Source: International Congress 2017 – Human susceptibility to tuberculosis
Year: 2017

Interferon-γ release assays for the diagnosis of latent tuberculosis infection in HIV-seropositive individuals
Source: Annual Congress 2008 - Interferon-gamma methods for the diagnosis of tuberculosis infection and disease
Year: 2008



The peculiarities of drug susceptibility of M. tuberculosis isolated from patients with late-stage HIV infection
Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities
Year: 2019

Utility of Th1-cell immune responses in differentiating active tuberculosis from latent tuberculosis infection
Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention
Year: 2014


Serum lipids as biomarkers for therapeutic monitoring of latent tuberculosis infection
Source: Eur Respir J 2013; 42: 547-550
Year: 2013


Utilisation of ELISA with Antigenic glycolipids in early diagnosis of pulmonary tuberculosis
Source: Eur Respir J 2002; 20: Suppl. 38, 315s
Year: 2002